Effects of visual feedback training on visual perception disorder combined with balance dysfunction after stroke

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059580

Enrollment

Unknown

Registered

2022-05-04

Start date

2022-06-06

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Contrast group:Routine rehabilitation training + routine drug therapy

Visual feedback group:Visual feedback training + routine rehabilitation training + routine drug therapy

Cognitive retraining group:Cognitive retraining group + routine rehabilitation training + routine drug therapy

Visual feedback + cognitive retraining group:Visual feedback training + cognitive retraining group + routine rehabilitation training + routine drug therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Balance dysfunction after stroke, excluding other causes; 2. Visual impairment after stroke, excluding other causes; 3. Simple Mental Scale (MMSE) >=24 points; 4. Berg Balance Scale (BBS) >=30 points; 5. Patients with first-time stroke understand and are willing to participate in this clinical trial and provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe aphasia; 2. Transient ischemic attack; 3. Unstable body condition; 4. Have hearing impairment; 5. Any eye disease; 6. Previous intraocular surgery; 7. History of other neurological diseases (multiple sclerosis, brain tumor, etc.) with other diseases that cause motor dysfunction; 8. Sequelae of fracture and limb deformity; 9. Balance center brain stem injury, cerebellar balance disorder.

Design outcomes

Primary

Measure	Time frame
Visual perception assessment;Berg Balance Scale;	—

Countries

China

Contacts

Public ContactZhang Nannan

The First Affiliated Hospital of Fujian Medical University

819046847@qq.com+86 18860103739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026